pd-1 inhibitor Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1 (2)
Phase 2 (1)

Interventional (3)

Big Ten Cancer Research Consortium (1)
Calico Life Sciences LLC (1)
Shanghai Pulmonary Hospital, Shanghai, China (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadinterstitial lung disease

I am/have/hadindolent lymphoma

I am/have/hadangina pectoris

I am/have/hadpsychiatric disorder

I am/have/hadhepatitis c

I am/have/hadanticoagulation therapy

I am/have/hadautograft

I am/have/hadulcerative

I am/have/hadlymphoma

I am/have/hadreplacement therapy

I am/have/hadendobronchial ultrasound

I am/have/hadcell transplantation

I am/have/hadros1

I am/have/hadautologous hematopoietic stem cell transplant

I am/have/hadhypothyroidism

I am/have/hadmeasurable disease

I am/have/hadthyroiditis

I am/have/hadcirrhosis

I am/have/hadhepatitis

I am/have/hadpsoriasis

added new label for I am/have/had

I am looking for

I am looking forapatinib

I am looking forangiogenesis inhibitor

I am looking forplatinum-based chemotherapy

I am looking forimmunosuppressive agents

I am looking forhormone therapy

I am looking forattenuated vaccines

I am looking forblockade

I am looking forpi3k inhibitor

I am looking forendocrine therapy

I am looking forcopanlisib

I am looking forrituximab

I am looking fororal contraceptives

I am looking forcamrelizumab

I am looking forcorticosteroids

I am looking forcyp3a4 inhibitors

I am looking forcyp3a4 inducers

I am looking foranticoagulants

I am looking forprednisone

I am looking forpd-1 inhibitor

I am looking forhepatitis b surface antigen

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

The participants will receive neoadjuvant PD-1 inhibitor (camrelizumab) combined with antiangiogenic drug (apatinib) or platinum-based chemotherapy.

kidney function test

anticoagulation therapy

apatinib

pulmonary function test

angiogenesis inhibitor

0 views
19 Feb, 2024

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

First In Human Study With ABBV-CLS-579 When Given Alone Or In Combination With Programmed Cell Death-1 Inhibitor In Participants With Locally Advanced Or Metastatic Tumors

In the combination therapy arm, escalating doses of ABBV-CLS-579 will be given in combination with a PD-1 inhibitor. Adult participants with a diagnosis of some solid tumors for which no effective standard therapy exists, or has failed will be enrolled.

0 views
19 Feb, 2024

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor Copanlisib Given in Combination With the Immunotherapeutic Agents Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

Patients with relapsed or refractory follicular or marginal zone lymphoma who have received at least one prior line of therapy will receive Copanlisib IV: day 1, 8, 15 every 28 days Nivolumab IV: Cycle 1 days 1 and 15; then day 1 only Rituximab IV: Cycle 1 days 1, 8, …

interstitial lung disease

indolent lymphoma

angina pectoris

psychiatric disorder

hepatitis c

0 views
19 Feb, 2024